Header

Sinclair

Our Key Products

Dermatology

Sinclair provides specific solutions to dermatologists and pharmacists for patients suffering from skin damage and skin injuries through its own operations in France, Italy and Spain and through its international network of marketing partners. It aims to do this by delivering higher value products with special attributes based on its surface treatment technologies and innovative    

delivery systems (foams, kits and sprays), treating major skin conditions such as acne, eczema, fungal conditions and addressing family dermatology and personal care needs. Core products in our Dermatology portfolio include Papulex, Sebclair, Bio-Taches, Atopiclair, Oxyplastine and DermaChronic.

  Product name Description Progress

Approved
EU/Other territories


Available in
10 countries

Papulex


 

Dermo-cosmetic range, consisting of five products, indicated for the management of acne-prone skin.

 

Contains the active ingredient nicotinamide (4%), chosen for its efficacy in preventing and treating inflammation.

Launches:

Spain May 2009
Algeria February 2009
Iran May 2009
Tunisia October 2009

 

2010 Milestones:
Planned launches in: India, Russia, Israel, and Saudi Arabi.

Approved
EU/US


Available in 

6 countries

Sebclair

 

Non-steroidal range of three products, available as a cream, shampoo and scalp fluid, indicated for the management of seborrhoeic dermatitis.

Launches:

Italy October 2008
Spain January 2009
Portugal October 2008
Turkey March 2009
Poland May 2009


2010 Milestones:
US launch of Sebclair cream through Dr Reddy’s in July 2009

 

Planned launches in USA, Bulgaria, Hungary, Czech Republic, Slovakia, and Lithuania

Approved
EU/Other territories


Available in
13 countries

Bio-Taches

 


Forms part of the Derma Omnium range, acquired by Sinclair in FY 2008.

 

Range of products indicated for the prevention and treatment of hyperpigmentations.

 

Product range comprises of an emulsion, a peel-off mask and two sun care products.

Launches:
Lebanon February 2009


2010 Milestones:
Planned launch in Egypt

 

Approved
EU/US/Other territories


Available in
14 countries

 

 Atopiclair

 


Non-steroidal range containing two products indicated for the symptomatic treatment of atopic dermatitis, including the relief and management of the most common signs and symptoms such as itching, burning and pain.

Launches:
Poland May 2009
Israel June 2009
South Korea August 2008


2010 Milestones:
Planned launches in India, the Netherlands, Belgium, Czech Republic, Slovakia, Bulgaria, and Lithuania

Read more